Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology
Disease Category: Solid Tumors

Trial Information

A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis

You have/your child has been asked to participate in this research study because you have/your child has either received a stem cell transplant and/or have/has leukemia (cancer of the blood or bone marrow) and your/your child’s doctor has determined that you/your child may have an invasive infection caused by a fungus know as Aspergillus. The purpose of this study is to compare treatment with a combination of antifungal medicines (voriconazole and anidulafungin) to treatment with voriconazole alone. Your/your child's participation in this study is expected to last 6 weeks for treatment with follow-up for an additional 6 weeks.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.